Michel Vounatsos
Förmögenhet: 3 M $ per 2026-05-31
Förmögenhet: 3 M $ per 2026-05-31
Michel Pericles Vounatsos is currently Chief Executive Officer & Director at Biogen Idec, Inc. (North Carolina) since 2017, Chief Executive Officer & Member-Supervisory Board at Biogen GmbH, Chairman-Supervisory Board at L’Institut de RYthmologie et Modélisation Cardiaque, Independent Director at Revvity, Inc. since 2020, Director at Revvity BV, Independent Director at Zai Lab Ltd. since 2023, and Director at n-Lorem Foundation.
Formerly, Mr. Vounatsos was Chief Executive Officer & Director at Biogen, Inc. from 2017 to 2022 and President-Primary Care & Customer Centricity at Merck & Co., Inc. from 2012 to 2016.
Education includes an MBA from École des Hautes Études Commerciales de Paris.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
REVVITY, INC. 0,01 % | 2026-05-07 | 13 977 ( 0,01 % ) | 1 M $ | 2026-05-31 |
ZAI LAB LTD. 0,06 % | 2026-06-17 | 727 870 ( 0,06 % ) | 1 M $ | 2026-05-31 |
| Företag | Position | Start |
|---|---|---|
| REVVITY, INC. | Direktör/Styrelseledamot | 2020-03-01 |
| ZAI LAB LIMITED | Direktör/Styrelseledamot | 2023-01-07 |
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Verkställande Direktör | 2017-01-06 |
Biogen GmbH
Biogen GmbH Pharmaceuticals: MajorHealth Technology Discovers, develops, manufactures and supplies pharmaceutical products | Verkställande Direktör | - |
L’Institut de RYthmologie et Modélisation Cardiaque | Ordförande | - |
n-Lorem Foundation
n-Lorem Foundation Miscellaneous Commercial ServicesCommercial Services Operates as a non profit organization for nano-rare patients | Direktör/Styrelseledamot | - |
Revvity BV
Revvity BV Medical SpecialtiesHealth Technology Manufactures and supplies laboratory equipment | Direktör/Styrelseledamot | - |
| Företag | Position | Slut |
|---|---|---|
| BIOGEN INC. | Verkställande Direktör | 2022-11-14 |
| MERCK & CO., INC. | Företagsledare/Principal | 2016-04-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 10 |
|---|---|
Merck & Co., Inc.
Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Revvity, Inc.
Revvity, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes reagents, analytical instruments and develops software | Health Technology |
École des Hautes Études Commerciales de Paris
École des Hautes Études Commerciales de Paris Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Revvity BV
Revvity BV Medical SpecialtiesHealth Technology Manufactures and supplies laboratory equipment | Health Technology |
Biogen GmbH
Biogen GmbH Pharmaceuticals: MajorHealth Technology Discovers, develops, manufactures and supplies pharmaceutical products | Health Technology |
Zai Lab Ltd.
Zai Lab Ltd. BiotechnologyHealth Technology Develops medicine for cancer, autoimmune and infectious diseases | Health Technology |
L’Institut de RYthmologie et Modélisation Cardiaque | |
n-Lorem Foundation
n-Lorem Foundation Miscellaneous Commercial ServicesCommercial Services Operates as a non profit organization for nano-rare patients | Commercial Services |
Välj din utgåva
All finansiell information anpassad till den nationella nivån